Information Collection

Rapid Message Testing with Consumer Panel - Drug Safety Communications About Misuse and Abuse of Over-the-Counter Medications (CDER)

IC 244796 under ICR 201712-0910-001 · OMB 0910-0695.

Documents and Forms

Information Collection (IC) Details

View Information Collection (IC)

layout table

Information Collection Instruments:
table that charts list of instruments
Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Other-Interview Guide Cognitive Interview Guide - Misuse and Abuse of OTCs.docx Yes Yes Printable Only
Other-Screener Screener - Misuse and Abuse of OTCs.docx Yes Yes Fillable Fileable
Other-DSC - Benadryl Drug Safety Communication for Benadryl.pdf Yes Yes Printable Only
Other-DSC - Immodium Drug Safety Communication for Imodium.pdf Yes Yes Printable Only
Other-DSC - Nasadine Drug Safety Communication for Nasadrine.pdf Yes Yes Printable Only

Federal Enterprise Architecture Business Reference Module


table that charts list of burden
  Approved Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 1,500 0 1,500 0 0 0
Annual IC Time Burden (Hours) 89 0 89 0 0 0
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Documents for IC
table that charts IC Documents
Title Document Date Uploaded
OMB Approval Memo 0695 OMB Approval Memo - Misuse and Abuse of OTC Medications 2020.docx 12/08/2020
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.